Overview
Mischa Koenen practices practicing medicine in Rotterdam, Netherlands.
Her clinical expertise encompasses Primary Immunodeficiency (PID) and Common Variable Immune Deficiency.
She is actively involved in clinical research, co-authoring 10 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mischa H. Koenen
Is Mischa H. Koenen a top-rated expert for Primary Immunodeficiency (PID)?
MediFind is an objective health platform that identifies experts based on real-world data. Mischa H. Koenen is classified as an Experienced expert for Primary Immunodeficiency (PID), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mischa H. Koenen participate in research or clinical trials?
Yes. Mischa H. Koenen has published 10 articles and abstracts on conditions like Primary Immunodeficiency (PID). You can view a list of Mischa H. Koenen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Common Variable Immune DeficiencyMs. Koenen isExperienced. Learn about Common Variable Immune Deficiency.
- Primary Immunodeficiency (PID)Ms. Koenen isExperienced. Learn about Primary Immunodeficiency (PID).